{"slug": "european-health-examination-survey-pilot-2010-final-report", "title": "EHES 2010 Pilot Study \u2013 Final Report", "pdfUrl": "https://dhir.gov.mt/wp-content/uploads/2024/04/european_health_examination_survey_pilot_2010_final_report.pdf", "sourcePage": "https://dhir.gov.mt/en/surveys/european-health-examination-survey-2010/", "group": "Survey", "topic": "European Health Examination Survey 2010", "tables": [{"caption": "Table 1: BMI Range(kg/m2)", "header": ["", "BMI Range(kg/m2)"], "rows": [["Normal Range", "18.50 \u2013 24.99"], ["Overweight", "25.00 \u2013 29.99"], ["Obese", "\u226530.00"]]}, {"caption": "Table 2: Increased Risk by Substantial Increased Risk", "header": ["", "Increased Risk", "Substantial Increased Risk"], "rows": [["Men", "\u226594cm", "\u2265102cm"], ["Women", "\u226580cm", "\u226588cm"]]}, {"caption": "Table 3: Systolic Diastolic", "header": ["", "", "Systolic                                  Diastolic"], "rows": [["Normal Blood Pressure", "", "<140mmHg            AND              <90mmHg"], ["Hypertension", "Stage 1", "\u2265140  \u2013 159mmHg         OR            \u226590  \u2013 99mmHg"], ["Hypertension", "Stage 2", "\u2264160mmHg             OR              \u2264100mmHg"]]}, {"caption": "Table 4: Total Cholest erol Serum (mmol/l)", "header": ["", "Total Cholest erol Serum (mmol/l)"], "rows": [["Desirable (lower risk)", "\u22645.00"], ["Borderline High (higher risk)", ">5.00  \u2013 6.18"], ["High (more than twice the risk as that for thedesirable level)", ">6.18"]]}, {"caption": "Table 5: LDL (mmol/l)", "header": ["", "LDL (mmol/l)"], "rows": [["Optimal or Near Optimal", "<3.34"], ["Borderline High", ">3.34  \u2013 4.13"], ["High", ">4.13  \u2013 4.90"], ["Very High", "> 4.90"]]}, {"caption": "Table 6: Snellen Fraction Range (m)", "header": ["", "", "Snellen Fraction Range (m)"], "rows": [["(Near-) Normal Vision", "Normal", "6/4  \u2013 6/8"], ["(Near-) Normal Vision", "Near Normal", "6/10  \u2013 6/20"], ["Low Vision", "Moderate Low  Vision", "6/25  \u2013 6/50"], ["Low Vision", "Severe Low Vision", "6/63  \u2013 6/125"], ["Low Vision", "Profound Low Vision", "6/160  \u2013 6/320"], ["(Near-) Blindness", "Near Blindness", "6/400  \u2013 6/630"], ["(Near-) Blindness", "Total Blindness", "No light perception"]]}, {"caption": "Table 1 Measured BMI by Gender", "header": ["", "Male", "Female", "Total"], "rows": [["Normal", "31.5%", "42.4%", "36.1%"], ["Overweight", "40.3%", "25.6%", "32.5%"], ["Obese", "28.2%", "32.0%", "29.8%"]]}, {"caption": "Table 2 Measured BMI by Age", "header": ["", "18 - 40", "41 - 60", "&gt;60"], "rows": [["Normal", "51.2%", "35.6%", "24.1%"], ["Overweight", "31.0%", "22.8%", "41.4%"], ["Obese", "17.9%", "35.6%", "34.5%"]]}, {"caption": "Table 3 Measured waist circumference by Gender", "header": ["", "Male", "Female"], "rows": [["Normal", "40.0%", "30.4%"], ["Increased Risk", "22.3%", "19.5%"], ["Substantial Risk", "37.8%", "50.0%"]]}, {"caption": "Table 4 Measured blood glucose by Gender", "header": ["", "Male", "Female", "Total"], "rows": [["% with elevated blood glucose", "9.0%", "10.7%", "9.8%"]]}, {"caption": "Table 5 Measured blood glucose by Age", "header": ["", "18 - 40", "41 - 60", "&gt;60"], "rows": [["% with elevated blood glucose", "0%", "12.2%", "21.6%"]]}, {"caption": "Table 6 Measured blood pressure by Gender", "header": ["", "Male", "Female", "Total"], "rows": [["% with elevated blood pressure", "41.4%", "38.8%", "41.7%"]]}, {"caption": "Table 7 Measured blood pressure by Age", "header": ["", "18 - 40", "41 - 60", "&gt;60"], "rows": [["% with elevated blood pressure", "12.4%", "46.0%", "85.5%"]]}, {"caption": "Table 8 Measured serum blood cholesterol", "header": ["", "%"], "rows": [["Desirable", "39.0%"], ["Borderline High", "40.2%"], ["High", "20.8%"]]}, {"caption": "Table 9 Measured LDL", "header": ["", "%"], "rows": [["Optimal or Near Optimal", "57.6%"], ["Borderline High", "29.5%"], ["High", "11.3%"], ["Very High", "1.6%"]]}]}